PRESSRELEASE --- PRESSRELEASE --- PRESSRELEASE --- PRESSRELEASE

Stockholm, 15 September 2008

Biosensor gets patent approved in China

Biosensor has been granted approval of an important patent by the Chinese patent authority, State Intellectual Property Office of the People’s Republic of China. The patent protects the complicated chemical design on the sensor surface that allows BIOSENS® to detect minute amounts of narcotics and explosives.

– This is one of the most important patents for our technology and it is obviously a break-through for Biosensor’s product portfolio when a large market’s patent authority approves this, says Biosensor’s chief development officer, Per Månsson.

The patent protects a significant part of Biosensor’s detection technology in the analysis instrument and makes it difficult for competitors to use this technology in the application are of BIOSENS®. The problem with narcotics is pervasive in China and therefore this patent protection will allow market activities to be strengthened there as well.

For additional information, please contact:

Bengt Hagander
President & CEO, Biosensor Applications Sweden AB (publ)

Telephone: 46 (0)8 706 75 00
bengt(punkt)hagander(snabel-a)biosensor(punkt)se

Biosensor is a Swedish company located in Sundbyberg, a suburb of Stockholm. The Company is listed on AktieTorget. The Company has developed a unique technology for detection of trace substances based on biotechnological sensors. This technology simultaneously detects both explosives and narcotics at a molecular level. The technology is distinguished by its very high probability of detection, with low false alarm rates outside laboratory environments. Biosensor’s customers are found among police forces, security companies, border control, the armed forces, the criminal justice system and rehabilitation clinics on a world-wide basis.